B. Abrahamsen

发表

Mechanisms of diabetes mellitus-induced bone fragility

A. Schwartz, N. Napoli, M. Chandran, 2017, Nature Reviews Endocrinology.

The Changing Role of Patient Education in Osteoporosis

B. Abrahamsen, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

Klaus Klaushofer, Piet Geusens, Regis O'Keefe, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures.

P. Schwarz, B. Abrahamsen, D. Brask-Lindemann, 2014, BoneKEy reports.

The role of vitamin D supplementation in patients with rheumatic diseases

N. Harvey, B. Abrahamsen, 2013, Nature Reviews Rheumatology.

Lactose avoidance and bone.

P. Vestergaard, B. Abrahamsen, 2017, Maturitas.

A pooled analysis of Vitamin D dose requirements for fracture prevention

A. Avenell, L. Rejnmark, A. Grey, 2013 .

A pooled analysis of Vitamin D dose requirements for fracture prevention

A. Avenell, L. Rejnmark, A. Grey, 2013 .

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

A. LaCroix, C. Cooper, R. Francis, 2010, BMJ : British Medical Journal.

Assessing Health Consequences of Vitamin D Fortification Utilizing a Societal Experiment Design: Methodological Lessons Learned from the D-Tect Project

B. Heitmann, A. Jensen, B. Abrahamsen, 2021, International journal of environmental research and public health.

Safety of bisphosphonates.

B. Abrahamsen, M. Pazianas, 2011, Bone.

Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.

G. Gislason, B. Abrahamsen, C. Binding, 2019, Journal of the American College of Cardiology.

Status of drug development for the prevention and treatment of osteoporosis

N. Jørgensen, P. Schwarz, B. Abrahamsen, 2014, Expert opinion on drug discovery.

Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency.

C. Hagen, M. Andersen, B. Abrahamsen, 2004, European journal of endocrinology.

Impact of hemodialysis on dual X-ray absorptiometry, bioelectrical impedance measurements, and anthropometry.

H. Beck-Nielsen, B. Abrahamsen, T. Hansen, 1996, The American journal of clinical nutrition.

Aetiology

B. Abrahamsen, 2020, Atlas of Endometriosis, Third Edition.

Cardiovascular disease in patients with osteogenesis imperfecta - a nationwide, register-based cohort study.

A. Hermann, J. Gram, L. Folkestad, 2016, International journal of cardiology.

Syddansk Universitet Cardiovascular disease in patients with osteogenesis imperfecta a nationwide , register-based cohort study

A. Hermann, J. Gram, A. Diederichsen, 2016 .

Association of a Common Allelic Polymorphism (C677T) in the Methylene Tetrahydrofolate Reductase Gene with a Reduced Risk of Osteoporotic Fractures. A Case Control Study in Danish Postmenopausal Women

B. Abrahamsen, J. S. Madsen, M. Fenger, 2002, Calcified Tissue International.

Vitamin D status and PTH in young men: a cross‐sectional study on associations with bone mineral density, body composition and glucose metabolism

M. Frost, M. Andersen, K. Brixen, 2010, Clinical endocrinology.

Eliminating the need for fasting with oral administration of bisphosphonates

R. Russell, B. Abrahamsen, S. Ferrari, 2013, Therapeutics and clinical risk management.

Nutrients, Diet, and Other Factors in Prenatal Life and Bone Health in Young Adults: A Systematic Review of Longitudinal Studies

B. Abrahamsen, M. N. Händel, K. H. Jensen, 2020, Nutrients.

Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports

R. Eastell, B. Abrahamsen, T. Vilaca, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The association between renal function and BMD response to bisphosphonate treatment Real-world cohort study using linked national registers

A. Hermann, B. Abrahamsen, M. Nybo, 2021 .

Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study

K. Brixen, B. Abrahamsen, J. S. Madsen, 2005, BMJ : British Medical Journal.

Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway

E. Skovlund, M. Hoff, A. Langhammer, 2021, Osteoporosis International.

Bisphosphonate Drug Holidays in Primary Care: When and What to Do Next?

D. Bauer, B. Abrahamsen, 2021, Current Osteoporosis Reports.

The association between renal function and BMD response to bisphosphonate treatment: Real-world cohort study using linked national registers.

A. Hermann, B. Abrahamsen, M. Nybo, 2020, Bone.

Adverse Effects of Drugs for Osteoporosis

B. Abrahamsen, D. Prieto-Alhambra, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population‐Based Cohort Study

C. Cooper, A. Díez-Pérez, R. Eastell, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Safety issues with bisphosphonate therapy for osteoporosis.

B. Abrahamsen, M. Pazianas, E. Suresh, 2014, Rheumatology.

Esophageal and gastric cancer incidence and mortality in alendronate users

R. Eastell, R. Russell, P. Eiken, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Older women who use bisphosphonate for longer than 5 years may have increased odds of a subtrochanteric or femoral shaft fracture, but absolute risk is low

B. Abrahamsen, 2011, Evidence Based Medicine.

Cytokines and Bone Loss in a 5‐Year Longitudinal Study—Hormone Replacement Therapy Suppresses Serum Soluble Interleukin‐6 Receptor and Increases Interleukin‐1‐Receptor Antagonist: The Danish Osteoporosis Prevention Study

H. Beck-Nielsen, J. Gram, B. Abrahamsen, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cardiovascular Safety of Denosumab Across Multiple Indications: A Systematic Review and Meta‐Analysis of Randomized Trials

P. Ebeling, B. Abrahamsen, Alexander J. Rodriguez, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Side effects of drugs for osteoporosis and metastatic bone disease.

M. Frost, B. Abrahamsen, M. Skjødt, 2018, British journal of clinical pharmacology.

University of Southern Denmark Side effects of drugs for osteoporosis and metastatic bone disease

M. Frost, B. Abrahamsen, M. Skjødt, 2018 .

Newly Diagnosed Celiac Disease and Bone Health in Young Adults: A Systematic Literature Review

J. Rumessen, B. Abrahamsen, M. N. Händel, 2022, Calcified tissue international.

A Common Methylenetetrahydrofolate Reductase (C677T) Polymorphism Is Associated With Low Bone Mineral Density and Increased Fracture Incidence After Menopause: Longitudinal Data From the Danish Osteoporosis Prevention Study

L. Mosekilde, S. Kristensen, K. Brixen, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study.

C. Hagen, M. Andersen, K. Brixen, 2006, Bone.

Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study.

L. Mosekilde, S. Kristensen, K. Brixen, 2005, Bone.

Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials.

J. Manson, C. Cooper, E. Jacobs, 2012, The Journal of clinical endocrinology and metabolism.

High calcium intake in men not women is associated with all-cause mortality risk: Melbourne Collaborative Cohort Study

D. English, G. Giles, P. Ebeling, 2018, Archives of Osteoporosis.

Risks and Benefits of Bisphosphonate Therapies

B. Abrahamsen, D. Prieto-Alhambra, M. Hitz, 2016, Journal of cellular biochemistry.

Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome

D. Glintborg, M. Andersen, B. Abrahamsen, 2017, The Journal of clinical endocrinology and metabolism.

Oral Bisphosphonate Use and All‐Cause Mortality in Patients With Moderate–Severe (Grade 3B‐5D) Chronic Kidney Disease: A Population‐Based Cohort Study

C. Cooper, A. Díez-Pérez, C. Tebé, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease

B. Abrahamsen, M. Cohen-Solal, G. Elder, 2021, Endocrine.

Reply to: systematic review and meta‐analysis for the association of bone mineral density and osteoporosis/osteopenia with vascular calcification in women

P. Ebeling, B. Abrahamsen, D. Scott, 2017, International journal of rheumatic diseases.

The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study

L. Rejnmark, A. Hermann, P. Eiken, 2022, BMC endocrine disorders.

Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density.

P. Ebeling, A. Hermann, B. Abrahamsen, 2020, The Journal of clinical endocrinology and metabolism.

Validation of the fracture risk evaluation model (FREM) in predicting major osteoporotic fractures and hip fractures using administrative health data.

S. Möller, J. Søndergaard, B. Abrahamsen, 2021, Bone.

Use of anti-osteoporotic drugs in central Norway after a forearm fracture

M. Hoff, A. Langhammer, H. Meyer, 2015, Archives of Osteoporosis.

Fractures in women with eating disorders-Incidence, predictive factors, and the impact of disease remission: Cohort study with background population controls.

A. Hermann, B. Abrahamsen, N. Bilenberg, 2020, The International journal of eating disorders.

Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway

E. Skovlund, M. Hoff, A. Langhammer, 2018, Osteoporosis International.

Prevention and treatment of osteoporosis in women: an update

K. Brixen, B. Abrahamsen, M. Kassem, 2009 .

Osteoarthritis in Osteogenesis Imperfecta: A Nationwide Register-based Cohort Study.

L. Folkestad, B. Abrahamsen, B. Langdahl, 2021, Bone.

Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular Risk.

L. Hegedüs, B. Abrahamsen, H. L. Jørgensen, 2019, Thyroid : official journal of the American Thyroid Association.

Over- and Under-Treatment of Hypothyroidism Is Associated with Excess Mortality: A Register-Based Cohort Study.

L. Hegedüs, B. Abrahamsen, H. L. Jørgensen, 2018, Thyroid : official journal of the American Thyroid Association.

Fracture Rates and Fracture Sites in Patients With Osteogenesis Imperfecta: A Nationwide Register‐Based Cohort Study

A. Ersbøll, A. Hermann, J. Gram, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register‐Based and Population‐Based Cohort Study

Kenneth H. Rubin, D. Glintborg, M. Andersen, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Duration of Thyroid Dysfunction Correlates with All-Cause Mortality. The OPENTHYRO Register Cohort

L. Hegedüs, B. Abrahamsen, M. Nybo, 2014, PloS one.

FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study

J. Kanis, L. Lix, E. McCloskey, 2022, Osteoporosis International.

Accelerated osteoarthritis in women with polycystic ovary syndrome: a prospective nationwide registry-based cohort study

D. Glintborg, M. Andersen, B. Abrahamsen, 2021, Arthritis Research & Therapy.

Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors

N. Jørgensen, P. Schwarz, B. Abrahamsen, 2017 .

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study

R. Eastell, R. Russell, P. Eiken, 2012, Osteoporosis International.

One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data

B. Abrahamsen, D. Prieto-Alhambra, C. Libanati, 2021, Osteoporosis International.

Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture prevention.

P. Vestergaard, B. Abrahamsen, M. Skjødt, 2019, Bone.

Osteoporosis treatment: bisphosphonates reign to continue for a few more years, at least?

B. Abrahamsen, M. Pazianas, 2016, Annals of the New York Academy of Sciences.

Prevention and treatment of osteoporosis in women

K. Brixen, B. Abrahamsen, M. Kassem, 2005 .

Site of Osteodensitometry in Perimenopausal Women: Correlation and Limits of Agreement Between Anatomic Regions

A. Hermann, P. Eiken, B. Abrahamsen, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Two Single Nucleotide Polymorphisms in the CYP17 and COMT Genes—Relation to Bone Mass and Longitudinal Bone Changes in Postmenopausal Women with or without Hormone Replacement Therapy

P. Vestergaard, L. Mosekilde, J. Gram, 2004, Calcified Tissue International.

Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.

L. Hegedüs, H. Beck-Nielsen, E. Eriksen, 2004, Bone.

Fracture risk following intermission of osteoporosis therapy

C. Cooper, S. Silverman, O. Bruyère, 2019, Osteoporosis International.

Ten-year prediction of osteoporosis from baseline bone mineral density: development of prognostic thresholds in healthy postmenopausal women. The Danish Osteoporosis Prevention Study

L. Rejnmark, L. Mosekilde, O. Bärenholdt, 2006, Osteoporosis International.

When Should Densitometry Be Repeated in Healthy Peri‐ and Postmenopausal Women: The Danish Osteoporosis Prevention Study

P. Vestergaard, A. Hermann, O. Bärenholdt, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications

C. Cooper, M. Javaid, B. Abrahamsen, 2021, Osteoporosis International.

Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.

R. Eastell, E. McCloskey, L. Hofbauer, 2020, The Journal of clinical endocrinology and metabolism.

Neonatal vitamin D status from archived dried blood spots and future risk of fractures in childhood: results from the D-tect study, a population-based case-cohort study.

C. Cooper, B. Heitmann, A. Cohen, 2017, American Journal of Clinical Nutrition.

Neonatal vitamin D status from archived dried blood spots and future risk of fractures in childhood: results from the D-tect study, a population-based case-cohort study.

C. Cooper, B. Heitmann, A. Cohen, 2017, The American journal of clinical nutrition.

Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study

N. Jørgensen, P. Oturai, P. Hovind, 2022, Osteoporosis International.

Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins.

P. Kostenuik, K. Kyvik, J. Hjelmborg, 2005, Bone.

Increased RANKL/OPG mRNA Ratio in Iliac Bone Biopsies From Women with Hip Fractures

M. Kassem, B. Abdallah, B. Abrahamsen, 2005, Calcified Tissue International.

Osteoprotegerin Levels in Primary Hyperparathyroidism: Effect of Parathyroidectomy and Association with Bone Metabolism

L. Hegedüs, H. Beck-Nielsen, B. Abrahamsen, 2003, Calcified Tissue International.

Effects of the Natural and Artificial Menstrual Cycle on the Production of Osteoprotegerin and the Bone Resorptive Cytokines IL-1b and IL-6

H. Beck-Nielsen, B. Abrahamsen, V. Bonnevie-Nielsen, 2002, Calcified Tissue International.

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group

M. Hiligsmann, O. Bruyère, P. Lips, 2022, Archives of Osteoporosis.

Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture—limitations and scope for fracture liaison services in prevention of hip fracture

P. Johansen, B. Abrahamsen, H. A. Sørensen, 2017, Osteoporosis International.

Screening: FRAX® in clinical practice

B. Abrahamsen, 2011, Nature Reviews Rheumatology.

Population-based reference values for bone mineral density in young men

M. Andersen, K. Brixen, B. Abrahamsen, 2007, Osteoporosis International.

Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects

J. Björk, B. Abrahamsen, B. Rosengren, 2016, Osteoporosis International.

Bisphosphonate adverse effects, lessons from large databases

B. Abrahamsen, 2010, Current opinion in rheumatology.

Response rates to oestrogen treatment in perimenopausal women: 5-year data from the Danish Osteoporosis Prevention Study (DOPS).

P. Vestergaard, L. Rejnmark, L. Mosekilde, 2004, Maturitas.

Improving compliance with hormonal replacement therapy in primary osteoporosis prevention.

P. Vestergaard, A. Hermann, J. Gram, 1997, Maturitas.

Adiponectin and Peak Bone Mass in Men: A Cross-Sectional, Population-Based Study

M. Frost, J. Frystyk, A. Flyvbjerg, 2010, Calcified Tissue International.

Correlations between insulin sensitivity and bone mineral density in non‐diabetic men

H. Beck-Nielsen, J. Henriksen, B. Abrahamsen, 2000, Diabetic medicine : a journal of the British Diabetic Association.

Periodontal health in a group of industrial employees.

B. Abrahamsen, T. Lie, O. Böe, 1988, Community dentistry and oral epidemiology.

Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: Results from the Danish Osteoporosis Prevention Study (DOPS)

L. Rejnmark, S. Kristensen, J. Jespersen, 2006, Thrombosis and Haemostasis.

Osteoporosis; Prevention and Ca—Vitamin D Treatment

B. Abrahamsen, 2019, Encyclopedia of Endocrine Diseases.

Effect of long‐term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study

L. Mosekilde, S. Kristensen, J. Jespersen, 2003, Journal of thrombosis and haemostasis : JTH.

Do calcium plus vitamin D supplements increase cardiovascular risk?

O. Sahota, B. Abrahamsen, 2011, BMJ : British Medical Journal.

Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report

S. Ralston, M. Kassem, P. Schwarz, 2018, Journal of Medical Case Reports.

Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society

R. Eastell, S. Ralston, M. Zillikens, 2019, The Journal of clinical endocrinology and metabolism.

The bisphosphonates: risks and benefits of long term use.

A. Hermann, B. Abrahamsen, 2013, Current opinion in pharmacology.

Atypical femur fractures: Refining the clinical picture

B. Abrahamsen, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures.

T. Einhorn, B. Abrahamsen, 2012, Bone.

Disentangling the Emerging Evidence around Atypical Fractures

B. Abrahamsen, E. Clark, 2012, Current Rheumatology Reports.

Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the danish national prescription database

B. Abrahamsen, 2012, Osteoporosis International.

Bone freezing and bisphosphonates.

B. Abrahamsen, 2011, Maturitas.

Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294))

T. Brown, P. Geusens, H. Genant, 2011 .

Subtrochanteric and diaphyseal fractures in patients during long-term alendronate treatment: Expanded and extended national register based cohort study

R. Eastell, P. Eiken, B. Abrahamsen, 2010 .

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

C. Cooper, J. Reginster, R. Rizzoli, 2017, Osteoporosis International.

Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study

P. Eiken, B. Abrahamsen, L. Bondø, 2012, Osteoporosis International.

Changes in bone mineral density (BMD) around the cemented Exeter stem: A prospective study in 18 women with 5 years follow‐up

K. Brixen, B. Abrahamsen, N. Nissen, 2008, Acta orthopaedica.

Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register‐Based Nationwide Cohort Study

A. Hermann, J. Gram, L. Folkestad, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Proton pump inhibitors and fracture risk. The HUNT study, Norway

E. Skovlund, M. Hoff, A. Langhammer, 2019, Osteoporosis International.

Polymorphisms in the Low-Density Lipoprotein Receptor-Related Protein 5 (LRP5) Gene Are Associated with Peak Bone Mass in Non-sedentary Men: Results from the Odense Androgen Study

M. Andersen, K. Brixen, B. Abrahamsen, 2007, Calcified Tissue International.

Does bisphosphonate treatment reduce the risk of future cancer?

B. Abrahamsen, M. Pazianas, 2019, Chinese clinical oncology.

Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women.

A. Hermann, F. Henriksen, J. Gram, 1998, Bone.

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

R. Horne, C. Cooper, M. Hiligsmann, 2017, Osteoporosis International.

Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial

J. K. Pedersen, T. Ellingsen, P. Junker, 2013, Annals of the rheumatic diseases.

Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study.

S. Kristensen, J. Jespersen, N. Klitgaard, 2002, American journal of obstetrics and gynecology.

More on reports of esophageal cancer with oral bisphosphonate use.

R. Eastell, P. Eiken, B. Abrahamsen, 2009, The New England journal of medicine.

Hormone Replacement Therapy Dissociates Fat Mass and Bone Mass, and Tends to Reduce Weight Gain in Early Postmenopausal Women: A Randomized Controlled 5‐Year Clinical Trial of the Danish Osteoporosis Prevention Study

P. Vestergaard, L. Mosekilde, H. Beck-Nielsen, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Risk factors for fracture in elderly men: a population-based prospective study

M. Frost, T. Masud, K. Brixen, 2012, Osteoporosis International.

Bespoke or one size fits all-Vitamin D fortification, targeted supplementation in risk groups or individual measurement?

B. Abrahamsen, 2017, Maturitas.

Two Polymorphisms in the Vitamin D Receptor Gene—Association With Bone Mass and 5‐Year Change in Bone Mass With or Without Hormone‐Replacement Therapy in Postmenopausal Women: The Danish Osteoporosis Prevention Study

B. Abrahamsen, L. Odum, C. Brot, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Risk of fracture in adults on renal replacement therapy: a Danish national cohort study.

J. Olesen, G. Gislason, B. Abrahamsen, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids

P. Eskildsen, P. Eiken, B. Abrahamsen, 2013, Osteoporosis International.

Epidemiology of Tumor-Induced Osteomalacia in Denmark

B. Abrahamsen, S. Minisola, Christopher D Smith, 2021, Calcified Tissue International.

The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study

L. Rejnmark, A. Hermann, P. Eiken, 2021, BMC Endocrine Disorders.

Diagnosis of osteoporosis by planar bone densitometry: can body size be disregarded?

A. Hermann, N. Kolthoff, O. Bärenholdt, 1998, The British journal of radiology.

Proton pump inhibitors and osteoporosis

P. Johansen, B. Abrahamsen, B. Andersen, 2016, Current opinion in rheumatology.

Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women.

P. Vestergaard, L. Mosekilde, A. Hermann, 2001, Maturitas.

Clinical Investigations Two Single Nucleotide Polymorphisms in the CYP17 and COMT Genes—Relation to Bone Mass and Longitudinal Bone Changes in Postmenopausal Women with or without Hormone Replacement Therapy The Danish Osteoporosis Prevention Study

P. Vestergaard, L. Mosekilde, J. Gram, 2004 .

Maternal serum retinol and β-carotene concentrations and neonatal bone mineralization: results from the Southampton Women’s Survey cohort1

C. Cooper, H. Inskip, P. Calder, 2016, The American journal of clinical nutrition.

Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population‐Based Cohort Study

C. Cooper, A. Díez-Pérez, R. Eastell, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Patients With Atypical Femur Fractures Have the Same Mortality as the Background Population—Drug‐Channeling Bias, Bisphosphonate Effects, and Public Health Implications

B. Abrahamsen, D. Prieto-Alhambra, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteoporosis epidemiology using international cohorts

M. Lorentzon, B. Abrahamsen, 2022, Current opinion in rheumatology.

Vitamin D insufficiency is associated with increased risk of first-trimester miscarriage in the Odense Child Cohort.

C. Dalgård, T. K. Jensen, H. Christesen, 2015, The American journal of clinical nutrition.

Utility of PINP to monitor osteoporosis treatment in primary care, the POSE study (PINP and Osteoporosis in Sheffield Evaluation).

R. Eastell, N. Peel, B. Abrahamsen, 2022, Bone.

Fractures following pregnancy in Osteogenesis imperfecta - a self-controlled case series using Danish Health Registers.

L. Folkestad, B. Abrahamsen, H. Kammerlander, 2021, Bone.

Association of Multimorbidity and Excess Mortality After Fractures Among Danish Adults

P. Geusens, J. Eisman, J. Center, 2022, JAMA network open.

The influence of early exposure to vitamin D for development of diseases later in life

A. Vaag, T. Sørensen, B. Heitmann, 2013, BMC Public Health.

Bone: Sequential osteoporosis treatment—the order of things

B. Abrahamsen, 2015, Nature Reviews Endocrinology.

Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study

N. Jørgensen, P. Oturai, P. Hovind, 2022, Osteoporosis International.

Vitamin D insufficiency is associated with increased risk of first-trimester miscarriage in the Odense Child Cohort 1 – 2

C. Dalgård, T. K. Jensen, H. Christesen, 2015 .

Vitamin D supplementation for musculoskeletal health outcomes in adults - The end of the beginning?

N. Harvey, B. Abrahamsen, 2019, Maturitas.

Relevance of Ki‐67 expression in the classification of non‐Hodgkin's lymphomas: a morphometric and double‐immunostaining study

B. Abrahamsen, A. Houmand, N. T. Pedersen, 1992, Histopathology.

Long term time trends in use of medications associated with risk of developing osteoporosis: Nationwide data for Denmark from 1999 to 2016.

B. Abrahamsen, M. Skjødt, Y. Ostadahmadli, 2019, Bone.

Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk

P. Vestergaard, P. Eiken, B. Abrahamsen, 2011, Osteoporosis International.

Hyperkalemia is Associated with Increased 30-Day Mortality in Hip Fracture Patients

C. M. Madsen, N. Jørgensen, O. Pedersen, 2017, Calcified Tissue International.

Season of Birth and the Risk of Hip Fracture in Danish Men and Women Aged 65+

B. Heitmann, P. Eiken, B. Abrahamsen, 2011, Front. Endocrin..

Excess mortality in men compared with women following a hip fracture — National analysis of comedications, comorbidity and survival

P. Eiken, B. Abrahamsen, P. Kannegaard, 2009 .

Primary hyperparathyroidism and fracture probability

J. Kanis, E. McCloskey, L. Rejnmark, 2022, Osteoporosis International.

Diagnostic devices for osteoporosis in the general population: A systematic review.

A. Hermann, K. Brixen, B. Abrahamsen, 2016, Bone.

The epidemiology of fractures in Denmark in 2011

P. Vestergaard, F. de Vries, J. V. D. van den Bergh, 2016, Osteoporosis International.

Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997–2006

P. Vestergaard, B. Abrahamsen, 2010, Osteoporosis International.

Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism.

S. Reppe, K. Gautvik, O. K. Olstad, 2007, American journal of physiology. Endocrinology and metabolism.

Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

Thomas D Brown, Klaus Klaushofer, Jeffrey R Curtis, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Excess mortality following hip fracture: a systematic epidemiological review

C. Cooper, M. Olson, B. Abrahamsen, 2009, Osteoporosis International.

Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study

A. Díez-Pérez, X. Nogués, B. Abrahamsen, 2017, Osteoporosis International.

A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.

J. Reginster, E. Orwoll, P. Miller, 2015, The Journal of clinical endocrinology and metabolism.

A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.

J. Reginster, S. Boonen, A. Grauer, 2012, The Journal of clinical endocrinology and metabolism.

Mapping the prescriptiome to fractures in men—a national analysis of prescription history and fracture risk

K. Brixen, B. Abrahamsen, Kim Brixen, 2009, Osteoporosis International.

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

C. Cooper, Y. Ben-Shlomo, N. Arden, 2021, Health technology assessment.

Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra.

H. Beck-Nielsen, K. Bendtzen, B. Abrahamsen, 1997, Bone.

Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome.

D. Glintborg, M. Andersen, B. Abrahamsen, 2015, European journal of endocrinology.

Osteoporosis and prostate cancer; a 24-month prospective observational study during androgen deprivation therapy

M. Frost, M. H. Poulsen, O. Gerke, 2019, Scandinavian journal of urology.

Osteoporosis and vertebral fractures in men aged 60-74 years.

M. Frost, C. Hagen, M. Andersen, 2012, Age and ageing.

The Duration and Safety of Osteoporosis Treatment: Anabolic and Antiresorptive Therapy

S. Silverman, B. Abrahamsen, 2016 .

Risk assessment tools to identify women with increased risk of osteoporotic fracture: Complexity or simplicity? A systematic review

Kim Brixen, Anne Pernille Hermann, Katrine Hass Rubin, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Persistence of Excess Mortality Following Individual Nonhip Fractures: A Relative Survival Analysis

P. Geusens, J. Eisman, J. Center, 2018, The Journal of clinical endocrinology and metabolism.

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies

B. Abrahamsen, Alexander J. Rodríguez, 2021, JBMR plus.

Cardiovascular and skeletal safety of zoledronic acid in osteoporosis observational, matched cohort study using Danish and Swedish health registries.

S. Möller, E. Eriksen, B. Abrahamsen, 2020, Bone.

Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus

C. Cooper, R. Eastell, W. Leslie, 2016 .

Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study

R. Eastell, P. Eiken, B. Abrahamsen, 2016, British Medical Journal.

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

P. Houillier, M. Brandi, J. Body, 2022, Journal of internal medicine.

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research

T. Brown, P. Geusens, H. Genant, 2011 .

The risk of osteoporosis in oral steroid treatment for nasal polyposis: a systematic review.

C. von Buchwald, C. Buchwald, B. Abrahamsen, 2017, Rhinology.

Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.

M. Bouxsein, D. Black, T. Einhorn, 2019, Endocrine reviews.

Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway

E. Skovlund, M. Hoff, A. Langhammer, 2017, Osteoporosis International.

Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.

M. Bech, A. Hermann, J. Hjelmborg, 2013, Bone.

[Angina pectoris after sumatriptan (Imigran)].

B. Abrahamsen, B. D. Christiansen, 1992, Ugeskrift for laeger.

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: Cohort analysis using a national prescription database

K. Brixen, P. Eiken, B. Abrahamsen, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Temporal trends in the use of antithrombotics at admission

C. M. Madsen, C. Jantzen, B. Abrahamsen, 2016, Acta orthopaedica.

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome

D. Glintborg, M. Andersen, B. Abrahamsen, 2018, Cardiovascular Diabetology.

University of Southern Denmark Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome

D. Glintborg, M. Andersen, B. Abrahamsen, 2018 .

Syddansk Universitet Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome

D. Glintborg, M. Andersen, B. Abrahamsen, 2018 .

Excess Mortality in Treated and Untreated Hyperthyroidism Is Related to Cumulative Periods of Low Serum TSH

L. Hegedüs, B. Abrahamsen, H. L. Jørgensen, 2017, The Journal of clinical endocrinology and metabolism.

Low Serum Thyrotropin Level and Duration of Suppression as a Predictor of Major Osteoporotic Fractures—The OPENTHYRO Register Cohort

L. Hegedüs, B. Abrahamsen, M. Nybo, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women.

V. Shalhoub, H. Beck-Nielsen, E. Eriksen, 2000, Bone.

Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.

Pia Eiken, Bo Abrahamsen, P. Eiken, 2010, Age and ageing.

Parity and tanned white skin as novel predictors of vitamin D status in early pregnancy: a population‐based cohort study

C. Dalgård, H. Christesen, H. Kyhl, 2013, Clinical endocrinology.

Safety of Oral Bisphosphonates in Moderate‐to‐Severe Chronic Kidney Disease: A Binational Cohort Analysis

C. Cooper, A. Díez-Pérez, C. Tebé, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Assessment of fracture risk in women with eating disorders: The utility of dual-energy x-ray absorptiometry (DXA)-Clinical cohort study.

A. Hermann, B. Abrahamsen, N. Bilenberg, 2020, The International journal of eating disorders.

Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy

K. Christensen, L. Rejnmark, S. Kristensen, 2007, Thrombosis and Haemostasis.

Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study.

P. Vestergaard, L. Mosekilde, L. Mosekilde, 2000, Maturitas.

Polymorphisms in the CYP19 and AR Genes—Relation to Bone Mass and Longitudinal Bone Changes in Postmenopausal Women With or Without Hormone Replacement Therapy: The Danish Osteoporosis Prevention Study

P. Vestergaard, L. Mosekilde, L. Mosekilde, 2003, Calcified Tissue International.

Epidemiological Factors Associated with Prescription of Opioids for Chronic Non-Cancer Pain in Adults: A Country-Wide, Registry-Based Study in Denmark Spans 2004–2018

B. Abrahamsen, M. Ernst, Christopher D. Smith, 2023, Journal of pain research.

Diabetes increases the risk of bone fractures in patients on kidney replacement therapy: A DANISH national cohort study.

J. Olesen, G. Gislason, B. Abrahamsen, 2021, Bone.

Socioeconomic status in Danish women with polycystic ovary syndrome: A register‐based cohort study

D. Glintborg, M. Andersen, B. Abrahamsen, 2018, Acta obstetricia et gynecologica Scandinavica.

Biochemical markers of inflammation are associated with increased mortality in hip fracture patients: the Bispebjerg Hip Fracture Biobank

N. Jørgensen, O. Pedersen, B. Abrahamsen, 2019, Aging Clinical and Experimental Research.

A New Fracture Risk Assessment Tool (FREM) Based on Public Health Registries

Kenneth H. Rubin, S. Möller, J. Søndergaard, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

University of Southern Denmark Socioeconomic status in Danish women with polycystic ovary syndrome. A register-based cohort study

D. Glintborg, M. Andersen, B. Abrahamsen, 2018 .

Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion

C. Cooper, A. Díez-Pérez, A. Pottegård, 2016, Calcified Tissue International.

Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register‐Based Nationwide Cohort Study

A. Hermann, J. Gram, L. Folkestad, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteo

C. Cooper, M. Hiligsmann, J. Reginster, 2019, Osteoporosis International.

Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry

L. Mosekilde, B. Abrahamsen, S. P. Nielsen, 2005, Osteoporosis International.

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group

M. Hiligsmann, O. Bruyère, P. Lips, 2022, Archives of Osteoporosis.

Hyponatremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients

C. M. Madsen, C. Jantzen, B. Abrahamsen, 2015, Osteoporosis International.

The calcium and vitamin D controversy

B. Abrahamsen, 2017, Therapeutic advances in musculoskeletal disease.

Ten‐Year Absolute Risk of Osteoporotic Fractures According to BMD T Score at Menopause: The Danish Osteoporosis Prevention Study

Kim Brixen, Peter Vestergaard, Bo Abrahamsen, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom

C. Cooper, M. Javaid, B. Abrahamsen, 2020, Osteoporosis International.

Nutrient and food intakes in early life and risk of childhood fractures: a systematic review and meta-analysis.

B. Heitmann, B. Abrahamsen, M. N. Händel, 2015, The American journal of clinical nutrition.

The Latest Evidence from Vitamin D Intervention Trials for Skeletal and Non-skeletal Outcomes

B. Abrahamsen, A. Sami, 2019, Calcified Tissue International.

Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment

N. Jørgensen, A. Hermann, R. Civitelli, 2007, Pharmacogenetics and genomics.

Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register‐Based National Cohort Study

R. Eastell, P. Eiken, B. Abrahamsen, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Epidemiology of Fractures in Diabetes

P. Vestergaard, M. Frost, B. Abrahamsen, 2017, Calcified Tissue International.

Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

A. Díez-Pérez, W. Lems, M. Brandi, 2023, BMJ.

Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients

N. Jørgensen, P. Schwarz, B. Abrahamsen, 2014, Osteoporosis International.

Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study

R. Eastell, P. Eiken, B. Abrahamsen, 2012, Osteoporosis International.

Proton pump inhibitor use and the antifracture efficacy of alendronate.

R. Eastell, P. Eiken, B. Abrahamsen, 2011, Archives of internal medicine.

Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.

R. Eastell, P. Eiken, B. Abrahamsen, 2010, The Journal of clinical endocrinology and metabolism.

Adverse Effects of Bisphosphonates

B. Abrahamsen, 2010, Calcified Tissue International.

Atrial fibrillation in fracture patients treated with oral bisphosphonates

K. Brixen, P. Eiken, B. Abrahamsen, 2009, Journal of internal medicine.

Discordance Between Changes in Bone Mineral Density Measured at Different Skeletal Sites in Perimenopausal Women—Implications for Assessment of Bone Loss and Response to Therapy: The Danish Osteoporosis Prevention Study

P. Vestergaard, A. Hermann, O. Bärenholdt, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A comparison of fracture risk assessment tools

W. Leslie, B. Abrahamsen, S. Morin, 2021 .

Fracture risk assessed by Fracture Risk Assessment Tool (FRAX) compared with fracture risk derived from population fracture rates

M. Bech, A. Hermann, J. Gram, 2011, Scandinavian journal of public health.

Pattern of use of DXA scans in men: a cross-sectional, population-based study

C. Gudex, M. Frost, K. Brixen, 2011, Osteoporosis International.

Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study

M. Bech, A. Hermann, J. Gram, 2011, Osteoporosis International.

Validation of a 5-year risk score of hip fracture in postmenopausal women. The Danish Nurse Cohort Study

R. Jacobsen, M. Davidsen, B. Abrahamsen, 2010, Osteoporosis International.

Oral Bisphosphonate Use and Total Knee/Hip Implant Survival: Validation of Results in an External Population‐Based Cohort

P. Vestergaard, N. Arden, B. Abrahamsen, 2014, Arthritis & rheumatology.

Regulation of bone mass in endocrine diseases including diabetes.

B. Abrahamsen, C. Higham, 2022, Best practice & research. Clinical endocrinology & metabolism.

Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements.

H. Beck-Nielsen, J. Gram, B. Abrahamsen, 1995, Bone.

Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult‐onset GH deficiency: results from two 12‐month randomized studies

C. Hagen, M. Andersen, P. Junker, 2002, Clinical endocrinology.

Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results

P. Eskildsen, B. Abrahamsen, S. Cadarette, 2011, Osteoporosis International.

Social inequality and fractures—secular trends in the Danish population: a case-control study

C. Cooper, P. Vestergaard, M. Javaid, 2018, Osteoporosis International.

Social inequality and fractures—secular trends in the Danish population a case-control study

A. Judge, N. Harvey, B. Abrahamsen, 2018 .

Fracture risk in Danish men with prostate cancer: a nationwide register study

P. Eskildsen, K. Brixen, B. Abrahamsen, 2007, BJU international.

Spawning of injured compared to uninjured female Atlantic salmon, Salmo salar L.

B. Abrahamsen, O. Berg, M. Berg, 1986 .

Women’s lived experiences of learning to live with osteoporosis: a longitudinal qualitative study

Birthe D. Pedersen, Bo Abrahamsen, B. Abrahamsen, 2017, BMC Women's Health.

Women's experiences of their osteoporosis diagnosis at the time of diagnosis and 6 months later: A phenomenological hermeneutic study

Birthe D. Pedersen, Bo Abrahamsen, B. Abrahamsen, 2014, International journal of qualitative studies on health and well-being.

The Excess Risk of Major Osteoporotic Fractures in Hypothyroidism Is Driven by Cumulative Hyperthyroid as Opposed to Hypothyroid Time: An Observational Register‐Based Time‐Resolved Cohort Analysis

L. Hegedüs, B. Abrahamsen, M. Nybo, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Antidepressant medications and osteoporosis.

C. Cooper, J. Reginster, V. Rabenda, 2012, Bone.

Low Levels of Hemoglobin at Admission Are Associated With Increased 30-Day Mortality in Patients With Hip Fracture

C. M. Madsen, B. Abrahamsen, J. Lauritzen, 2016, Geriatric orthopaedic surgery & rehabilitation.

Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM)

Kenneth H. Rubin, J. Kanis, L. Lix, 2021, Osteoporosis International.

Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective

P. Vestergaard, K. Brixen, P. Eiken, 2015, Osteoporosis International.

No Association Between Hip Geometry and Four Common Polymorphisms Associated with Fracture: The Danish Osteoporosis Prevention Study

N. Jørgensen, K. Brixen, E. Bladbjerg, 2009, Calcified Tissue International.

Disproportional geometry of the proximal femur in patients with Turner syndrome: a cross‐sectional study

L. Mosekilde, K. Brixen, B. Abrahamsen, 2007, Clinical endocrinology.

Denosumab: A novel antiresorptive drug for osteoporosis

B. Abrahamsen, E. Suresh, 2015, Cleveland Clinic Journal of Medicine.

Bisphosphonates and atypical fracture

B. Abrahamsen, 2014 .

Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence

P. Eiken, B. Abrahamsen, C. Roerholt, 2009, Osteoporosis International.

‘Skeletal Age’ for mapping the impact of fracture on mortality

J. Center, Tuan V. Nguyen, P. Vestergaard, 2022, medRxiv.

Predicting Imminent Fractures in Patients With a Recent Fracture or Starting Oral Bisphosphonate Therapy: Development and International Validation of Prognostic Models

M. Javaid, B. Abrahamsen, D. Prieto-Alhambra, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The emperor redressed: treating osteoporosis to prevent hip fractures in the oldest old

B. Abrahamsen, 2017, Journal of internal medicine.

Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription Data

C. Cooper, C. Osmond, B. Abrahamsen, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted

R. Russell, B. Abrahamsen, M. Pazianas, 2013, BMJ.

Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.

P. Vestergaard, B. Abrahamsen, 2013, Bone.

Technology evaluation: denosumab, Amgen.

B. Abrahamsen, A. Y. Teng, 2005, Current opinion in molecular therapeutics.

Standardization of BMD T-Scores in the first five years after the menopause: do femoral neck-equivalent and older normative range T-Scores improve diagnostic agreement?

P. Vestergaard, L. Mosekilde, H. Beck-Nielsen, 2003, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study

C. Cooper, E. Dennison, N. Harvey, 2015, Archives of Osteoporosis.

Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism.

S. Reppe, K. Gautvik, O. K. Olstad, 2006, Bone.

Essentials in rheumatology: disease managementI34. Metabolic bone diseases

R. Horne, Paul Wordsworth, C. Cooper, 2012 .

Vitamin D receptor polymorphism does not predict bone density or rate of bone loss in perimenopausal danish women

H. Beck-Nielsen, J. Gram, B. Abrahamsen, 2006, Osteoporosis International.

Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk.

L. Hegedüs, B. Abrahamsen, T. Brix, 2019, European journal of endocrinology.

Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures - the openthyro register cohort

L. Hegedüs, B. Abrahamsen, M. Nybo, 2014 .

Syddansk Universitet Excess mortality in treated and untreated hyperthyroidism is related to cumulative periods of low serum

L. Hegedüs, B. Abrahamsen, T. Brix, 2017 .

Prenatal exposure to vitamin D from fortified margarine and risk of fractures in late childhood: period and cohort results from 222 000 subjects in the D-tect observational study

C. Cooper, C. Osmond, B. Heitmann, 2017, The British journal of nutrition.

Geometry of the proximal femur in relation to age and sex: a cross-sectional study in healthy adult danes

L. Mosekilde, E. Hauge, K. Brixen, 2005, Acta radiologica.

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users

R. Eastell, P. Eiken, B. Abrahamsen, 2017, Osteoporosis International.

[Compliance with the treatment of osteoporosis with diphosphonates. A questionnaire among postmenopausal women].

K. Brixen, B. Abrahamsen, C. Ejersted, 2004, Ugeskrift for læger.

Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs—an analysis using national health databases

K. Olsen, B. Abrahamsen, C. Hansen, 2013, Osteoporosis International.

Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high‐resolution pQCT

J. Gram, L. Folkestad, K. Brixen, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Compliance to bisphosphonates - a population-based study using a drug prescription database

M. Andersen, K. Brøsen, K. Brixen, 2000 .

AGE AT HIP FRACTURE AND LIFE EXPECTANCY IN DENMARK - SECULAR TRENDS OVER TWO DECADES.

P. Vestergaard, B. Abrahamsen, M. H. Jensen, 2019, Bone.

Women's experiences of their osteoporosis diagnosis at the time of diagnosis and 6 months later: A phenomenological hermeneutic study.

B. Abrahamsen, B. Pedersen, H. Konradsen, 2014, International journal of qualitative studies on health and well-being.

SOCIAL INEQUALITY AND HIP FRACTURE: SECULAR TRENDS IN THE DANISH POPULATION

P. Vestergaard, M. Javaid, A. Judge, 2015 .

Explaining declining hip fracture rates in Norway: a population-based modelling study

M. O’Flaherty, G. Tell, H. Meyer, 2023, The Lancet regional health. Europe.

Tramadol prescribed use in general and chronic noncancer pain: a nationwide register-based cohort study of all patients above 16 years

B. Abrahamsen, M. Stougaard, M. Ernst, 2019, Scandinavian journal of pain.

Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy

M. Frost, M. H. Poulsen, K. Brixen, 2014, Scandinavian journal of urology.

Syddansk Universitet Risk of hip , subtrochanteric , and femoral shaft fractures among mid and long term users of alendronate nationwide cohort and nested case-control study

R. Eastell, P. Eiken, B. Abrahamsen, 2016 .

Healthcare costs associated with opportunistically identifiable vertebral fractures.

K. Olsen, B. Abrahamsen, C. Libanati, 2023, Bone.

Fracture Risk in Men and Women With Vertebral Fractures Identified Opportunistically on Routine Computed Tomography Scans and Not Treated for Osteoporosis: An Observational Cohort Study

K. Olsen, B. Abrahamsen, C. Libanati, 2023, JBMR plus.

Diagnosis and management of bone fragility in diabetes: an emerging challenge

R. Eastell, W. Leslie, A. Schwartz, 2018, Osteoporosis International.

Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study

D. Glintborg, M. Andersen, B. Abrahamsen, 2019, Endocrine connections.

Age at first major osteoporotic fracture in Danes aged 50 and over: influence of diabetes on mean age at fracture and 1 year mortality

C. Cooper, N. Napoli, B. Abrahamsen, 2015 .

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases

B. Abrahamsen, M. Pazianas, Y. Wang, 2012, Osteoporosis International.

Pre-fracture medication use as a predictor of 30-day mortality in hip fracture patients: an analysis of 141,201 patients

C. M. Madsen, J. Howland, C. Jantzen, 2020, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

Excess mortality following hip fracture in patients with diabetes according to age: a nationwide population-based cohort study of 154,047 hip fracture patients.

C. M. Madsen, C. Jantzen, B. Abrahamsen, 2019, Age and ageing.

Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials.

J. Manson, C. Cooper, E. Jacobs, 2012, The Journal of clinical endocrinology and metabolism.

Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.

M. Bouxsein, D. Black, T. Einhorn, 2018, Endocrine reviews.

Risks and Benefits of Bisphosphonate Therapies

B. Abrahamsen, D. Prieto-Alhambra, M. Hitz, 2016, Journal of cellular biochemistry.

University of Southern Denmark Prenatal exposure to vitamin D from fortified margarine and risk of fractures in late childhood period and cohort results from 222 000 subjects in the D-tect observational study

C. Osmond, B. Heitmann, B. Abrahamsen, 2017 .

A New Fracture Risk Assessment Tool (FREM) Based on Public Health Registries

Kenneth H. Rubin, S. Möller, J. Søndergaard, 2018, Journal of Bone and Mineral Research.

More on reports of esophageal cancer with oral bisphosphonate use.

R. Eastell, P. Eiken, B. Abrahamsen, 2009, The New England journal of medicine.

SP0117 CASE 2 DISCUSSANT: AUTOMATED (IMPLEMENTED IN ELECTRONIC MEDICAL RECORD SYSTEMS) SHORT-TERM FRACTURE RISK PREDICTION

B. Abrahamsen, 2019, Speaker Abstracts.

Diagnostic devices for osteoporosis in the general population: A systematic review.

A. Hermann, K. Brixen, B. Abrahamsen, 2016, Bone.

Risk factors for post peak bone loss and osteoporotic fracture: lessons from population studies

B. Abrahamsen, 2018 .

Central nervous system medications and falls risk in men aged 60-75 years: the Study on Male Osteoporosis and Aging (SOMA).

M. Frost, T. Masud, K. Brixen, 2013, Age and ageing.

Beyond a reasonable doubt?: Bisphosphonates and atypical femur fractures - a clinical debate

T. Einhorn, B. Abrahamsen, 2012 .

Women's experiences of their osteoporosis diagnosis at the time of diagnosis and 6 months later: A phenomenological hermeneutic study

B. Abrahamsen, B. Pedersen, H. Konradsen, 2014, International journal of qualitative studies on health and well-being.

New insights in the pathophysiology, epidemiology and response to treatment of osteoporotic vertebral fractures.

B. Abrahamsen, M. Skjødt, 2023, The Journal of clinical endocrinology and metabolism.

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

T. Brown, P. Geusens, H. Genant, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register‐Based Nationwide Cohort Study

A. Hermann, J. Gram, L. Folkestad, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.